HEXAGON CAPITAL PARTNERS LLC – Eli Lilly and Company Transaction History
HEXAGON CAPITAL PARTNERS LLC portfolio value:
$196,000
portfolio value
HEXAGON CAPITAL PARTNERS LLC quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +11.01% | 60 shares | 19K | $323.35 | 605 |
| Q2 2022 | share | Decrease | -26.65% | -198 shares | -36K | $324.23 | 545 |
| Q1 2022 | share | Decrease | -5.95% | -47 shares | -5K | $286.37 | 743 |
| Q4 2021 | share | Decrease | -10.53% | -93 shares | 14K | $277.25 | 790 |
| Q3 2021 | share | Increase | +10.38% | 83 shares | 20K | $230.3 | 883 |
| Q2 2021 | share | Decrease | -11.11% | -100 shares | 16K | $228.04 | 800 |
| Q1 2021 | share | Decrease | -38.36% | -560 shares | -78K | $184.81 | 900 |
| Q4 2020 | share | Decrease | -4.58% | -70 shares | 45K | $166.32 | 1.46K |
| Q3 2020 | share | Increase | 0.00% | 1.53K shares | 201K | $145.05 | 1.53K |